Shanghai Labway Clinical Laboratory Co., Ltd.
SZSE:301060.SZ
12.86 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 429.218 | 450.408 | 436.441 | 404.492 | 431.966 | 425.322 | 412.588 | 1,090.479 | 1,048.169 | 1,232.967 | 827.69 | 503.748 | 503.294 | 414.894 | 356.397 | 374.467 | 363.201 | 341.232 | 159.29 | 325.491 | 241.293 | 241.293 | 245.551 | 245.551 | 156.773 | 156.773 | 185.369 | 185.369 | 118.866 | 118.866 |
Cost of Revenue
| 356.782 | 355.306 | 340.837 | 367.238 | 336.353 | 329.888 | 292.606 | 660.583 | 651.468 | 666.102 | 430.734 | 325.026 | 296.031 | 261.726 | 218.437 | 266.611 | -333.746 | 333.746 | 148.7 | 0 | 164.93 | 164.93 | 174.589 | 174.589 | 92.769 | 92.769 | 119.214 | 119.214 | 78.264 | 78.264 |
Gross Profit
| 72.436 | 95.102 | 95.604 | 37.254 | 95.613 | 95.434 | 119.982 | 429.896 | 396.702 | 566.866 | 396.956 | 178.722 | 207.262 | 153.168 | 137.96 | 107.857 | 696.947 | 7.486 | 10.59 | 325.491 | 76.363 | 76.363 | 70.961 | 70.961 | 64.003 | 64.003 | 66.155 | 66.155 | 40.602 | 40.602 |
Gross Profit Ratio
| 0.169 | 0.211 | 0.219 | 0.092 | 0.221 | 0.224 | 0.291 | 0.394 | 0.378 | 0.46 | 0.48 | 0.355 | 0.412 | 0.369 | 0.387 | 0.288 | 1.919 | 0.022 | 0.066 | 1 | 0.316 | 0.316 | 0.289 | 0.289 | 0.408 | 0.408 | 0.357 | 0.357 | 0.342 | 0.342 |
Reseach & Development Expenses
| 15.448 | 17.391 | 9.986 | 16.162 | 13.068 | 8.88 | 10.754 | 61.078 | 16.615 | 19.215 | 12.493 | 16.448 | 7.731 | 9.203 | 6.059 | 5.951 | 6.083 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | -19.475 | 41.857 | -76.174 | 113.505 | -20.653 | 42.503 | -155.19 | 208.594 | -25.394 | 62.505 | -62.933 | 107.136 | 44.859 | 28.541 | 33.044 | 33.163 | 0 | 0 | 0 | 33.067 | 33.067 | 34.15 | 34.15 | 22.379 | 22.379 | 17.886 | 17.886 | 13.363 | 13.363 |
Selling & Marketing Expenses
| 0 | 20.546 | 17.251 | 28.87 | 23.431 | 25 | 21.386 | 47.58 | 40.053 | 54.926 | 41.562 | 48.257 | 23.943 | 29.181 | 24.102 | 28.281 | 20.584 | 0 | 0 | 0 | 14.869 | 14.869 | 21.586 | 21.586 | 9.868 | 9.868 | 10.022 | 10.022 | 5.616 | 5.616 |
SG&A
| 73.011 | 67.939 | 59.108 | -47.304 | 136.936 | 4.347 | 63.888 | -107.61 | 248.647 | 29.532 | 104.067 | -14.677 | 131.08 | 81.056 | 58.043 | 76.689 | 48.907 | 0 | 0 | 0 | 47.936 | 47.936 | 55.736 | 55.736 | 32.247 | 32.247 | 27.908 | 27.908 | 18.979 | 18.979 |
Other Expenses
| -63.464 | -3.078 | -0.402 | -12.261 | -0.158 | -2.085 | -15.365 | 262.336 | -147.467 | 147.975 | -2.288 | 126.137 | -56.139 | -343.944 | -278.729 | -344.351 | -629.479 | 62.805 | -148.7 | -301.937 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 151.923 | 88.408 | 68.32 | 103.132 | 82.701 | 77.286 | 59.277 | 215.804 | 117.794 | 196.722 | 114.272 | 127.908 | 82.672 | -343.944 | -278.729 | -344.351 | -629.479 | 62.805 | -148.7 | -301.937 | 48.252 | 48.252 | 55.113 | 55.113 | 36.194 | 36.194 | 29.972 | 29.972 | 21.796 | 21.796 |
Operating Income
| -79.488 | 6.694 | 2.721 | -141.496 | 11.802 | -28.673 | 22.543 | 56.544 | 258.646 | 354.359 | 279.726 | 48.128 | 122.201 | 70.95 | 77.668 | 30.117 | 67.469 | 70.291 | 10.59 | 23.554 | 31.962 | 31.962 | 14.231 | 14.231 | 31.024 | 31.024 | 37.339 | 37.339 | 20.948 | 20.948 |
Operating Income Ratio
| -0.185 | 0.015 | 0.006 | -0.35 | 0.027 | -0.067 | 0.055 | 0.052 | 0.247 | 0.287 | 0.338 | 0.096 | 0.243 | 0.171 | 0.218 | 0.08 | 0.186 | 0.206 | 0.066 | 0.072 | 0.132 | 0.132 | 0.058 | 0.058 | 0.198 | 0.198 | 0.201 | 0.201 | 0.176 | 0.176 |
Total Other Income Expenses Net
| 3.884 | 2.668 | -0.402 | -12.261 | 3.111 | -2.085 | -4.793 | -44.238 | -6.395 | -2.678 | -1.808 | -1.185 | 0.818 | 3.299 | -0.304 | -2.593 | -3.657 | -1.718 | -8.19 | 0.716 | -2.565 | -2.565 | 1.617 | 1.617 | -3.214 | -3.214 | -1.155 | -1.155 | -2.141 | -2.141 |
Income Before Tax
| -75.603 | 9.362 | 2.319 | -153.757 | 11.643 | -30.757 | 19.628 | 24.361 | 251.747 | 351.681 | 276.655 | 46.943 | 123.019 | 70.705 | 77.364 | 27.524 | 63.811 | 68.573 | 2.4 | 24.27 | 29.397 | 29.397 | 15.849 | 15.849 | 27.81 | 27.81 | 36.183 | 36.183 | 18.807 | 18.807 |
Income Before Tax Ratio
| -0.176 | 0.021 | 0.005 | -0.38 | 0.027 | -0.072 | 0.048 | 0.022 | 0.24 | 0.285 | 0.334 | 0.093 | 0.244 | 0.17 | 0.217 | 0.074 | 0.176 | 0.201 | 0.015 | 0.075 | 0.122 | 0.122 | 0.065 | 0.065 | 0.177 | 0.177 | 0.195 | 0.195 | 0.158 | 0.158 |
Income Tax Expense
| -12.598 | -1.479 | 2.584 | -1.415 | 3.214 | 2.63 | 4.037 | 18.229 | 45.533 | 56.129 | 45.497 | 10.422 | 19.615 | 298.056 | -254.685 | 716.699 | -692.056 | 157.651 | -139.025 | 725.032 | 6.693 | 6.693 | 7.143 | 7.143 | 6.411 | 6.411 | 9.318 | 9.318 | 4.517 | 4.517 |
Net Income
| -56.181 | 14.526 | 1.072 | -140.711 | 0.943 | -23.236 | 15.591 | 6.132 | 173.77 | 253.309 | 177.239 | 36.521 | 79.182 | 44.861 | 53.32 | 17.536 | 45.983 | 54.133 | -7.275 | 13.57 | 21.798 | 21.798 | 8.039 | 8.039 | 21.343 | 21.343 | 26.866 | 26.866 | 14.29 | 14.29 |
Net Income Ratio
| -0.131 | 0.032 | 0.002 | -0.348 | 0.002 | -0.055 | 0.038 | 0.006 | 0.166 | 0.205 | 0.214 | 0.072 | 0.157 | 0.108 | 0.15 | 0.047 | 0.127 | 0.159 | -0.046 | 0.042 | 0.09 | 0.09 | 0.033 | 0.033 | 0.136 | 0.136 | 0.145 | 0.145 | 0.12 | 0.12 |
EPS
| -0.14 | 0.036 | 0.003 | -0.35 | 0.002 | -0.058 | 0.039 | 0.015 | 0.43 | 0.63 | 0.44 | 0.091 | 0.2 | 0.11 | 0.15 | 0.044 | 0.11 | 0.14 | -0.018 | 0.034 | 0.17 | 0.17 | 0.083 | 0.083 | 0.23 | 0.23 | 0.295 | 0.11 | 0.044 | 0.04 |
EPS Diluted
| -0.14 | 0.036 | 0.003 | -0.35 | 0.002 | -0.058 | 0.039 | 0.015 | 0.43 | 0.63 | 0.44 | 0.091 | 0.2 | 0.11 | 0.15 | 0.044 | 0.11 | 0.14 | -0.018 | 0.034 | 0.17 | 0.17 | 0.083 | 0.083 | 0.23 | 0.23 | 0.295 | 0.11 | 0.044 | 0.04 |
EBITDA
| -73.448 | 36.374 | 15.355 | -151.823 | 35.993 | -7.899 | 43.036 | 56.862 | 283.988 | 373.884 | 298.049 | 47.585 | 136.056 | -206.831 | 86.695 | 23.932 | 776.131 | -72.92 | 14.247 | -700.652 | 38.201 | 38.201 | 19.058 | 19.058 | 35.88 | 35.88 | 40.678 | 40.678 | 23.638 | 23.638 |
EBITDA Ratio
| -0.171 | 0.068 | 0.069 | -0.191 | 0.032 | 0.038 | 0.142 | 0.166 | 0.259 | 0.299 | 0.341 | 0.102 | 0.254 | -0.498 | 1 | -1.807 | 2.14 | -0.214 | 1 | -2.14 | 0.158 | 0.158 | 0.078 | 0.078 | 0.229 | 0.229 | 0.219 | 0.219 | 0.199 | 0.199 |